<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00336089</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000466676</org_study_id>
    <secondary_id>CSU-GCC-161</secondary_id>
    <nct_id>NCT00336089</nct_id>
  </id_info>
  <brief_title>Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors</brief_title>
  <official_title>The Effects of Cross Training on Fatigue and Pain Levels in Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clayton State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: An exercise program or health education program may help relieve fatigue and pain&#xD;
      and improve the quality of life in women who are breast cancer survivors. It is not yet known&#xD;
      whether an exercise program is more effective than a health education program or no program&#xD;
      in reducing fatigue and pain in women who are breast cancer survivors.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial is studying an exercise program to see how well it&#xD;
      works in reducing fatigue and pain compared to a health education program or no program in&#xD;
      women who are breast cancer survivors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Determine whether a moderate-intensity exercise program comprising cardiorespiratory and&#xD;
           resistance training of the legs, back, abdominal, trunk, and arm musculature vs a&#xD;
           control group attenuates fatigue and pain in breast cancer survivors.&#xD;
&#xD;
        -  Determine whether this exercise program will significantly improve the quality of life&#xD;
           of these patients.&#xD;
&#xD;
        -  Determine whether this exercise program can significantly reduce the number of days of&#xD;
           absenteeism from work in these patients.&#xD;
&#xD;
        -  Determine whether this exercise program can significantly attenuate mood disturbances in&#xD;
           these patients.&#xD;
&#xD;
      OUTLINE: This is a randomized, controlled, pilot study. Patients are randomized to 1 of 2&#xD;
      treatment arms.&#xD;
&#xD;
        -  Arm I (exercise program): Patients participate in an exercise program comprising&#xD;
           cardiorespiratory (walking on a treadmill) and resistance training for 1 hour, 3 times&#xD;
           weekly for 12 weeks.&#xD;
&#xD;
        -  Arm II (control): Patients undergo no intervention. In both arms, patients complete&#xD;
           questionnaires regarding general health, mood, work attendance, and physical activity&#xD;
           before the start of study treatment and then every 3 weeks for 12 weeks. Patients also&#xD;
           complete a 7-day physical activity diary and sleep diary every 3 weeks.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 54 patients will be accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2006</start_date>
  <primary_completion_date type="Anticipated">December 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
  </study_design_info>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Cancer Survivor</condition>
  <condition>Fatigue</condition>
  <condition>Pain</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>exercise intervention</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>educational intervention</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>complementary or alternative medicine procedure</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fatigue assessment and management</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>management of therapy complications</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pain therapy</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Breast cancer survivor&#xD;
&#xD;
          -  Received adjuvant chemotherapy or radiotherapy for breast cancer only&#xD;
&#xD;
               -  Must have completed treatment 2-6 months ago&#xD;
&#xD;
          -  Hormone receptor status not specified&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Menopausal status not specified&#xD;
&#xD;
          -  Hemoglobin â‰¥ 11 g/dL&#xD;
&#xD;
          -  Able to read English&#xD;
&#xD;
          -  No high-risk for cardiovascular problems during exercise, including any of the&#xD;
             following:&#xD;
&#xD;
               -  Unstable heart disease&#xD;
&#xD;
               -  Unstable angina&#xD;
&#xD;
               -  Chronic respiratory disease&#xD;
&#xD;
               -  Dizziness&#xD;
&#xD;
               -  Uncontrolled hypertension&#xD;
&#xD;
          -  No severe respiratory disease requiring oxygen therapy&#xD;
&#xD;
          -  No history of anorexia (body mass index [BMI] &lt; 18.5) or severe obesity (BMI &gt; 35)&#xD;
&#xD;
          -  No history of multiple cancers&#xD;
&#xD;
          -  No shortness of breath or hypotension&#xD;
&#xD;
          -  No sudden swelling of the ankles, hands or face&#xD;
&#xD;
          -  No palpitations or arrhythmias&#xD;
&#xD;
          -  No persistent and intolerable pain&#xD;
&#xD;
          -  No major acute illness (e.g., fever or respiratory infection)&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melanie Poudevigne, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clayton State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Joseph's Hospital of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342-1701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Saint Joseph's Hospital of Atlanta</last_name>
      <phone>404-851-7115</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clayton State University</name>
      <address>
        <city>Morrow</city>
        <state>Georgia</state>
        <zip>30260-0285</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Poudevigne, PhD</last_name>
      <phone>678-466-4937</phone>
      <email>mpoudevigne@clayton.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>June 8, 2006</study_first_submitted>
  <study_first_submitted_qc>June 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 12, 2006</study_first_posted>
  <last_update_submitted>September 16, 2013</last_update_submitted>
  <last_update_submitted_qc>September 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2013</last_update_posted>
  <keyword>fatigue</keyword>
  <keyword>pain</keyword>
  <keyword>cancer survivor</keyword>
  <keyword>breast cancer in situ</keyword>
  <keyword>inflammatory breast cancer</keyword>
  <keyword>stage IA breast cancer</keyword>
  <keyword>stage IB breast cancer</keyword>
  <keyword>stage II breast cancer</keyword>
  <keyword>stage IIIA breast cancer</keyword>
  <keyword>stage IIIB breast cancer</keyword>
  <keyword>stage IIIC breast cancer</keyword>
  <keyword>stage IV breast cancer</keyword>
  <keyword>recurrent breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

